Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2023

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jun-2018   |    Format :PDF   |    Number of Pages : 111
This report studies the global Alzheimer's Disease Therapeutics and Diagnostics market status and forecast, categorizes the global Alzheimer's Disease Therapeutics and Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer's disease. One in nine people aged 65 and above has Alzheimer's disease. By 2050, the number of people aged 65 and above affected with Alzheimer's disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. The mortality rates due to Alzheimer’s disease are quite high. Between 2000 and 2013, deaths due to heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, while deaths from AD increased 71% in the U.S. Similarly, According to Alzheimer’s disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimer’s therapeutics and diagnostics worldwide. 
Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players.  Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.
The global Alzheimer's Disease Therapeutics and Diagnostics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
    Namenda
    Aricept
    Exelon
    Solanezumab
    Gantenerumab
    Verubecestat
    Pfizer
    Eisai
    Actavis
    Lundbeck
    Daiichi Sankyo
    Novartis
    TauRx

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Biomarkers
    Cholinesterase inhibitors
    NMDA receptor antagonists
    Brain imaging
    Blood tests
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Drugs Market
    Diagnostics Market

The study objectives of this report are:
    To analyze and study the global Alzheimer's Disease Therapeutics and Diagnostics sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Alzheimer's Disease Therapeutics and Diagnostics players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alzheimer's Disease Therapeutics and Diagnostics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Alzheimer's Disease Therapeutics and Diagnostics Manufacturers
Alzheimer's Disease Therapeutics and Diagnostics Distributors/Traders/Wholesalers
Alzheimer's Disease Therapeutics and Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Alzheimer's Disease Therapeutics and Diagnostics market, by end-use.
Detailed analysis and profiles of additional market players.

Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Report 2018
1 Alzheimer's Disease Therapeutics and Diagnostics Market Overview
    1.1 Product Overview and Scope of Alzheimer's Disease Therapeutics and Diagnostics
    1.2 Classification of Alzheimer's Disease Therapeutics and Diagnostics by Product Category
        1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Biomarkers
        1.2.4 Cholinesterase inhibitors
        1.2.5 NMDA receptor antagonists
        1.2.6 Brain imaging
        1.2.7 Blood tests
    1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market by Application/End Users
        1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.1 Drugs Market
        1.3.2 Diagnostics Market
    1.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market by Region
        1.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
        1.4.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
        1.4.4 China Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
        1.4.5 Japan Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
        1.4.7 India Alzheimer's Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Alzheimer's Disease Therapeutics and Diagnostics (2013-2025)
        1.5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2025)
        1.5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2025)

2 Global Alzheimer's Disease Therapeutics and Diagnostics Competition by Players/Suppliers, Type and Application
     2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Competition by Players/Suppliers
        2.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Alzheimer's Disease Therapeutics and Diagnostics (Volume and Value) by Type
        2.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
        2.2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
    2.3 Global Alzheimer's Disease Therapeutics and Diagnostics (Volume and Value) by Region
        2.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales and Market Share by Region (2013-2018)
        2.3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Market Share by Region (2013-2018)
    2.4 Global Alzheimer's Disease Therapeutics and Diagnostics (Volume) by Application

3 United States Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    3.1 United States Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        3.1.1 United States Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        3.1.2 United States Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        3.1.3 United States Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    3.2 United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

4 Europe Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    4.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        4.1.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        4.1.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    4.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

5 China Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    5.1 China Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        5.1.1 China Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        5.1.2 China Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        5.1.3 China Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    5.2 China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    5.3 China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    5.4 China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

6 Japan Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    6.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        6.1.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        6.1.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    6.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    7.1 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        7.1.1 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    7.2 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

8 India Alzheimer's Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
    8.1 India Alzheimer's Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
        8.1.1 India Alzheimer's Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
        8.1.2 India Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
        8.1.3 India Alzheimer's Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
    8.2 India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
    8.3 India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
    8.4 India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

9 Global Alzheimer's Disease Therapeutics and Diagnostics Players/Suppliers Profiles and Sales Data
    9.1 Namenda
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Aricept
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 Exelon
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 Solanezumab
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Gantenerumab
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Verubecestat
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Pfizer
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 Eisai
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 Actavis
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 Lundbeck
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Alzheimer's Disease Therapeutics and Diagnostics Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview
    9.11 Daiichi Sankyo
    9.12 Novartis
    9.13 TauRx

10 Alzheimer's Disease Therapeutics and Diagnostics Maufacturing Cost Analysis
    10.1 Alzheimer's Disease Therapeutics and Diagnostics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Alzheimer's Disease Therapeutics and Diagnostics
    10.3 Manufacturing Process Analysis of Alzheimer's Disease Therapeutics and Diagnostics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Alzheimer's Disease Therapeutics and Diagnostics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Alzheimer's Disease Therapeutics and Diagnostics Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast (2018-2025)
    14.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Price and Trend Forecast (2018-2025)
    14.2 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Forecast by Type (2018-2025)
       14.3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Forecast by Type (2018-2025)
       14.3.3 Global Alzheimer's Disease Therapeutics and Diagnostics Price Forecast by Type (2018-2025)
    14.4 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Alzheimer's Disease Therapeutics and Diagnostics
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Comparison (K Units) by Type (2013-2025)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (Product Category) in 2017
    Figure Biomarkers Product Picture
    Figure Cholinesterase inhibitors Product Picture
    Figure NMDA receptor antagonists Product Picture
    Figure Brain imaging Product Picture
    Figure Blood tests Product Picture
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Comparison (K Units) by Application (2013-2025)
    Figure Global Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application in 2017
    Figure Drugs Market Examples
    Table Key Downstream Customer in Drugs Market
    Figure Diagnostics Market Examples
    Table Key Downstream Customer in Diagnostics Market
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Million USD) by Regions (2013-2025)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate (2013-2025)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
    Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
    Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Market Share by Type (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (K Units) by Type (2013-2018)
    Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Type (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Type (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Region (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Region (2013-2018)
    Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Region in 2017
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Region in 2017
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region in 2017
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Application (2013-2018)
    Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application (2013-2018)
    Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
    Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
    Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
    Table Namenda Basic Information List
    Table Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
    Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
    Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
    Table Aricept Basic Information List
    Table Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
    Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
    Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
    Table Exelon Ba



Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...